Nikos Explorations Ltd. (CVE:NIK), a gold junior, surged after signing a LOI to acquire gold properties in Labrador
Sean Mason | September 11, 2017 | SmallCapPower
Speculators reacted positively to a gold junior Monday following the acquisition of gold properties from a famous prospector. Here’s some small stocks making big moves on Monday, September 11, 2017 (as of 4 pm EST):
Nikos Explorations Ltd. (TSXV: NIK) shares shot up 56% to $0.14 on Monday after the gold junior announced that it has signed a Letter of Intent with Shawn Ryan to acquire gold properties in Labrador.
As well, shares of ESSA Pharma Inc. (TSX: EPI) plunged 38% to $0.37 as the pharmaceutical company revealed results from the Phase 1 portion of the Phase 1/2 clinical trial of EPI-506 for the treatment of metastatic castration-resistant prostate cancer that was presented at the European Society for Medical Oncology.
CVR Medical Corp. (TSXV: CVM), meanwhile, reported that an institutional research report has been released by RB Milestone Group, LLC on CVR Medical titled “Revolutionizing the Vascular Diagnostics Market.” CVR Medical stock moved up 20% to $0.455 following the announcement.
Finally, POET Technologies Inc. (TSXV: PTK) shares continued to move higher Monday before slipping 3% to close at $0.35. On Friday, POET stock surged 22% after announcing that its wholly-owned subsidiary, DenseLight Semiconductors, has introduced a new family of its specialized external cavity narrow linewidth laser products with enhanced capabilities.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
